This Edition
ARTICLE | Company News
Proteonomix dermatology, cardiovascular, gene/cell therapy news
WIR Staff
June 27, 2011 7:00 AM UTC
At March 31, Proteonomix reported $925 in cash and a three-month operating loss of $280,097. ...